Average Insider

Where insiders trade, we follow

$CVSI
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect distributors, brick and mortar retailers, and select e-tailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. This segment is developing drug candidate CVSI-007 that combines CBD and nicotine in treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Joseph D. Dowling
CEO
47
Employees
$0.01
Current Price
$9.21M
Market Cap
52W Low$0.01
Current$0.013.1% above low, 96.9% below high
52W High$0.10

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys14$39,406.823,940,682All Buys
Sells00--
1 monthBuys15$54,409.265,440,926All Buys
Sells00--
2 monthsBuys15$54,409.265,440,926All Buys
Sells00--
3 monthsBuys15$54,409.265,440,926All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 9, 2026
CHEEVER CHARLIE E III
10% Owner
Purchase1,980,969$0.01$19,809.69View Details
Nov 5, 2026
CHEEVER CHARLIE E III
10% Owner
Purchase1,076,508$0.01$10,765.08View Details
Nov 6, 2026
CHEEVER CHARLIE E III
10% Owner
Purchase500,000$0.01$5,000.00View Details
Nov 4, 2026
CHEEVER CHARLIE E III
10% Owner
Purchase1,500,244$0.01$15,002.44View Details
Nov 11, 2026
CHEEVER CHARLIE E III
10% Owner
Purchase383,205$0.01$3,832.05View Details
10 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 16, 2026
EPS
Estimated-$0.02
ActualN/A
Revenue
Estimated$5.21M
ActualN/A
Nov 12, 2026
EPS
Estimated-$0.02
Actual-$0.00
Beat
Revenue
Estimated$5.21M
Actual$3.03M
Miss
1 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.11.1